You have accessJournal of UrologyCME1 May 2022MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DATA Khalid Alkhatib, Muhieddine Labban, Logan Briggs, David-Dan Nguyen, Peter Herzog, Alexander P. Cole, Austin Haag, and Quoc-Dien Trinh Khalid AlkhatibKhalid Alkhatib More articles by this author , Muhieddine LabbanMuhieddine Labban More articles by this author , Logan BriggsLogan Briggs More articles by this author , David-Dan NguyenDavid-Dan Nguyen More articles by this author , Peter HerzogPeter Herzog More articles by this author , Alexander P. ColeAlexander P. Cole More articles by this author , Austin HaagAustin Haag More articles by this author , and Quoc-Dien TrinhQuoc-Dien Trinh More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002641.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Limited data exist on prostate cancer screening behaviors in U.S. military veterans who receive universal access to care through the Veterans Health Administration or regular civilian care facilities. We sought to analyze the effect of veteran status on prostate-specific antigen (PSA) screening to examine the effect of veteran status on receipt of prostate-specific antigen (PSA) screening and more specifically whether access to the Veterans Health System mitigates racial disparities in PSA screening. METHODS: A cross-sectional analysis of non-Hispanic White (NHW) and non-Hispanic Black (NHB) men aged 55-69 who responded to the PSA screening survey was conducted using the 2018 Behavioral Risk Factor Surveillance System data. A bivariate analysis and a complex weighted multivariable logistic regression model were used to evaluate predictors of PSA screening, including the interaction between race and veteran status. an institutional review board waiver was obtained. RESULTS: Screening prevalence was higher among veterans (43.2%, 95% confidence interval (CI) 41.6% - 44.9%) versus non-veterans (39.6%, 95% CI 38.66% - 40.45%), p<0.001. Among non-veterans, the prevalence of PSA screening was significantly lower in NHB (34.1%, 95% CI 31.1% - 37.1%) versus NHW (40.3%, 95% CI 39.3% - 41.2), p<0.001. Among veterans, NHB men had a significant higher screening prevalence (48.4%, 95% CI 42.9% - 53.9%) versus NHW men (42.3%, 95% CI 40.5% - 44.1), p=0.037. We found that veteran status (OR 1.1, CI 1.01 – 1.20, p=0.030) and NHB race (OR 1.28, CI 1.11 – 1.47, p<0.001) were significantly associated with receipt of PSA screening (Table 1). A significant positive interaction was found between veteran status and race (pint=0.030). CONCLUSIONS: Veteran status and NHB race were found to be independent predictors of PSA screening. The interaction between veteran status and race suggests that access to health coverage available to veterans may mitigate racial differences in prostate cancer screening behaviors. Alternatively, differential preventive cancer screening behaviors among military health care providers may explain the differences. Further studies are needed to translate such findings into the civilian health care system. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e998 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Khalid Alkhatib More articles by this author Muhieddine Labban More articles by this author Logan Briggs More articles by this author David-Dan Nguyen More articles by this author Peter Herzog More articles by this author Alexander P. Cole More articles by this author Austin Haag More articles by this author Quoc-Dien Trinh More articles by this author Expand All Advertisement PDF DownloadLoading ...
Read full abstract